Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
  banglasesh pharmaceuticals market  


This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Executive Summary

Bangladesh is one of the ten most populous countries in the world. It is also one of the poorest. Access to even the most basic of healthcare provision remains sub-standard, despite the ongoing efforts of the government, aided by considerable international assistance. Adequate secondary or tertiary care is beyond the reach of all but a very few people. Government hospitals are often little more than clinics, and suffer from severe shortages of trained staff. There is a growing private hospital sector, largely based in Dhaka, which caters for the well-off. It is in the private sector where the most advanced services are located, and where almost all pharmaceutical demand is found.

Given the country's lack of spending power, the pharmaceutical market, at US$682 million, remains tiny in comparison with the size of the population. Pharmaceutical spending is amongst the lowest in the world in per capita terms. Steadily improving economic performance, combined with a general determination to boost the quality of healthcare, should lead to modest, if unspectacular, market growth. An increase in investment in Bangladesh by multinational pharmaceutical manufacturers is also anticipated to stimulate the sector. The revised National Drug Policy was introduced in 2005 with the hope of attracting foreign multinational investment and revitalising the health sector in the long term. In addition the emergence of Beximco, the leading domestic manufacturer, offers encouraging signs for the future, although the company did experience a marginal decline in turnover in 2007. The market is dominated by cheap, locally produced generic drugs used for the treatment or prevention of basic illnesses and conditio


Medical center


capsule capsule

 Print page   Send by mai


  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market




About Taj


Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors


Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement